Related Experiment Video
Updated: Jun 8, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage
Eva Pericolini1, Elena Gabrielli, Giovanni Bistoni
1Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy.
Abstract:
Previously, we reported that Galactoxylomannan (GalXM) activates the extrinsic and intrinsic apoptotic pathways through an interaction with the glycoreceptors on T cells. In this study we establish the role of the glycoreceptor CD45 in GalXM-induced T cell apoptosis, using CD45(+/+) and CD45(-/-) cell lines, derived from BW5147 murine T cell lymphoma. Our results show that whereas CD45 expression is not required for GalXM association by the cells, it is essential for apoptosis induction. In CD45(+/+) cells, CD45 triggering by GalXM reduces the activation of Lck, ZAP70 and Erk1/2. Conversely, in CD45(-/-) cells, Lck was hyperphosphorylated and did not show any modulation after GalXM stimulation. On the whole, our findings provide evidence that the negative regulation of Lck activation occurs via CD45 engagement. This appears to be related to the capacity of GalXM to antagonize T cell activation and induce T cell death. Overall this mechanism may be responsible for the immune paralysis that follows GalXM administration and could explain the powerful immunosuppression that accompanies cryptococcosis.
Insights
Galactoxylomannan (GalXM) induces T cell death by interacting with CD45, a key glycoreceptor. This interaction negatively regulates Lck activation, leading to immune paralysis and immunosuppression in cryptococcosis.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Galactoxylomannan (GalXM) previously shown to activate apoptotic pathways in T cells via glycoreceptor interaction.
- The specific role of glycoreceptor CD45 in GalXM-mediated T cell apoptosis was not fully elucidated.
Purpose of the Study:
- To establish the role of the glycoreceptor CD45 in Galactoxylomannan (GalXM)-induced T cell apoptosis.
- To investigate the molecular mechanisms by which GalXM affects T cell signaling pathways through CD45.
Main Methods:
- Utilized CD45(+/+) and CD45(-/-) cell lines derived from BW5147 murine T cell lymphoma.
- Assessed GalXM association with T cells and measured the phosphorylation status of key signaling molecules (Lck, ZAP70, Erk1/2) following GalXM stimulation.
Main Results:
- CD45 expression is not required for GalXM binding to T cells but is essential for GalXM-induced apoptosis.
- In CD45(+/+) cells, GalXM triggering reduced Lck, ZAP70, and Erk1/2 activation.
- In CD45(-/-) cells, Lck was hyperphosphorylated and unaffected by GalXM stimulation, indicating CD45's role in negative regulation.
Conclusions:
- CD45 engagement by GalXM negatively regulates Lck activation, contributing to T cell apoptosis.
- This mechanism explains GalXM's capacity to antagonize T cell activation and induce immune paralysis.
- The findings provide insight into the immunosuppression observed in cryptococcosis.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Extrinsic Apoptotic Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

